Clearstead Advisors’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
PCM
Clearstead Advisors's BCAT Position: Q2 2026 in Review
Clearstead Advisors held its BlackRock Capital Allocation Term Trust (BCAT) position steady in Q2 2026 at 83,423 shares worth $1.33M. The position accounts for 0.01% of the portfolio, ranked #480.
Clearstead Advisors first reported a position in BCAT in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.44M in Q2 2024. 110 funds tracked by Wall St. Rank hold BCAT as of Q2 2026.
- Clearstead Advisors held 83,423 shares of BlackRock Capital Allocation Term Trust worth $1.33M as of Q2 2026.
- Clearstead Advisors left its BlackRock Capital Allocation Term Trust share count unchanged in Q2 2026.
- BlackRock Capital Allocation Term Trust made up 0.01% of Clearstead Advisors's portfolio in Q2 2026, its #480 holding.
- Clearstead Advisors first reported a position in BlackRock Capital Allocation Term Trust in Q2 2024 and has held it in 9 quarters since.
- Clearstead Advisors's BlackRock Capital Allocation Term Trust position peaked at $1.44M in Q2 2024.
- 110 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2026.
Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.